Haleon (LON:HLN) Trading 0.5% Higher - Here's What Happened

Key Points

• Haleon shares rose 0.5% to GBX 369.90, reaching an intraday high of GBX 373.70. Trading volume was 14% above the average, with roughly 30.5 million shares changing hands.
• Analyst views remain mixed: the consensus rating is “Hold”, with an average price target of GBX 399. Recent targets range from GBX 315 to GBX 514, reflecting buy, hold and sell assessments.
• Haleon reported quarterly EPS of GBX 8.60, alongside a 14.55% net margin and 9.89% return on equity. Analysts expect full-year EPS of approximately GBX 19.50.

Haleon plc (LON:HLN - Get Free Report) traded up 0.5% during trading on Tuesday . The company traded as high as GBX 373.70 and last traded at GBX 369.90. 30,502,482 shares were traded during mid-day trading, an increase of 14% from the average daily volume of 26,647,273 shares. The stock had previously closed at GBX 368.20.

Analysts Set New Price Targets

Several brokerages recently commented on HLN. Royal Bank Of Canada lifted their price target on shares of Haleon from GBX 370 to GBX 390 and gave the stock a "sector perform" rating in a research note on Tuesday, August 11th. Berenberg Bank upped their price objective on shares of Haleon from GBX 512 to GBX 514 and gave the company a "buy" rating in a research note on Wednesday, August 5th. Jefferies Financial Group reaffirmed a "buy" rating and set a GBX 400 price objective on shares of Haleon in a report on Friday, July 31st. Deutsche Bank Aktiengesellschaft lifted their target price on Haleon from GBX 325 to GBX 335 and gave the stock a "sell" rating in a research report on Friday, July 31st. Finally, JPMorgan Chase & Co. reduced their target price on Haleon from GBX 335 to GBX 315 and set an "underweight" rating for the company in a report on Thursday, June 25th. Three analysts have rated the stock with a Buy rating, one has assigned a Hold rating and two have given a Sell rating to the company's stock. According to data from MarketBeat, Haleon has an average rating of "Hold" and a consensus price target of GBX 399.

Haleon Stock Up 0.5%

The firm has a market capitalization of £32.58 billion, a PE ratio of 20.44, a PEG ratio of 1.49 and a beta of 0.24. The business's fifty day moving average price is GBX 362.87 and its 200 day moving average price is GBX 360.63. The company has a quick ratio of 0.93, a current ratio of 0.69 and a debt-to-equity ratio of 50.38.

Haleon (LON:HLN - Get Free Report) last released its quarterly earnings results on Thursday, July 30th. The company reported GBX 8.60 earnings per share (EPS) for the quarter. Haleon had a return on equity of 9.89% and a net margin of 14.55%. On average, equities research analysts forecast that Haleon plc will post 19.5033282 earnings per share for the current fiscal year.

Haleon Company Profile

Haleon LSE / NYSE: HLN is a world-leading consumer health company, with a clear purpose to deliver better everyday health with humanity. In July 2022, it listed as an independent company on the London and New York Stock Exchanges. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on trusted science, innovation and deep human understanding.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source